Voyager Therapeutics Inc
NASDAQ:VYGR

Watchlist Manager
Voyager Therapeutics Inc Logo
Voyager Therapeutics Inc
NASDAQ:VYGR
Watchlist
Price: 3.8 USD -2.06%
Market Cap: 207.6m USD
Have any thoughts about
Voyager Therapeutics Inc?
Write Note

Wall Street
Price Targets

VYGR Price Targets Summary
Voyager Therapeutics Inc

Wall Street analysts forecast VYGR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VYGR is 16.42 USD with a low forecast of 9.09 USD and a high forecast of 31.5 USD.

Lowest
Price Target
9.09 USD
139% Upside
Average
Price Target
16.42 USD
332% Upside
Highest
Price Target
31.5 USD
729% Upside
Voyager Therapeutics Inc Competitors:
Price Targets
VLA
Valneva SE
116% Upside
DVYSR
Devyser Diagnostics AB
58% Upside
MOLN
Molecular Partners AG
201% Upside
PRAX
Praxis Precision Medicines Inc
169% Upside
IDYA
IDEAYA Biosciences Inc
187% Upside
GNS
Genus PLC
26% Upside
BMRN
Biomarin Pharmaceutical Inc
38% Upside
TGTX
TG Therapeutics Inc
3% Upside

Revenue
Forecast

Revenue Estimate
Voyager Therapeutics Inc

For the last 8 years the compound annual growth rate for Voyager Therapeutics Inc's revenue is 40%. The projected CAGR for the next 4 years is -25%.

40%
Past Growth
-25%
Estimated Growth
Estimates Accuracy
5%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Voyager Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
Voyager Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-46%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VYGR's stock price target?
Price Target
16.42 USD

According to Wall Street analysts, the average 1-year price target for VYGR is 16.42 USD with a low forecast of 9.09 USD and a high forecast of 31.5 USD.

What is Voyager Therapeutics Inc's Revenue forecast?
Projected CAGR
-25%

For the last 8 years the compound annual growth rate for Voyager Therapeutics Inc's revenue is 40%. The projected CAGR for the next 4 years is -25%.

Back to Top